Page 12 - Aadi Bioscience News Today

Office leasing gained some in Q2, seeing 2.8 million square feet of activity, according to Colliers, driven by life sciences.

Shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) have been assigned a consensus rating of “Buy” from the six research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price […]

LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing...

Target tumor reductions observed in advanced malignant PEComa patients harboring TSC1 or TSC2 inactivating alterations regardless of prior mTOR inhibitor...

Aadi Bioscience (NASDAQ:AADI – Get Rating) announced its quarterly earnings results on Thursday. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.68) by $0.02, MarketWatch Earnings reports. During the same quarter in the previous year, the firm posted ($0.90) EPS. Shares of Aadi Bioscience stock opened at […]

Aadi Bioscience (NASDAQ:AADI – Get Rating) announced its earnings results on Thursday. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.68) by $0.02, MarketWatch Earnings reports. During the same quarter last year, the company earned ($0.90) EPS. Shares of NASDAQ:AADI opened at $14.02 on Friday. Aadi Bioscience […]

FYARRO net product sales of $2.3 million in partial first quarterDosing of patients initiated in PRECISION 1, a Phase 2 tumor-agnostic...

Brokerages forecast that Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) will announce sales of $510,000.00 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Aadi Bioscience’s earnings. The highest sales estimate is $780,000.00 and the lowest is $250,000.00. The business is scheduled to announce its next quarterly earnings results before […]

Company to hold conference call on May 12th at 8:30 am EDT...

Shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) have received a consensus rating of “Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective […]